Frequency estimation OF tuberculosis with extensively drug resistance in patients of diff erent registration groups
Abstract
Aim: to estimate the share of tuberculosis with extensively drug resistance in TB patients with a different history of treatment in Russian Federation.
Materials. Тhe results of the survey of patients with multidrugresistant tuberculosis in public (24,464) and penitentiary (1,780) health care were studied.
Results. The share of cases of extensively drug-resistant tuberculosis among cases of multidrug-resistant tuberculosis was 13.6% in public and 11.0% in the penitentiary sector, which is higher than the global rates. In homogeneous registration groups in the civil and penitentiary sector, it is comparable, and for new cases it is 8.0% (95% CI 7.4–8.5%), for cases of relapse - 13.5% (95% CI 12.3–14.7%), in other retreatment cases – 17.4% (95% CI 15.7–19.1%). The risk of extensively drug-resistant Mycobacterium tuberculosis in cases of re-treatment of 1.7 (in the cases of tuberculosis relapse) – 2.2 (in the other retreatment cases) times higher than that of new TB cases.
Conclusion. The obtained results substantiate the expediency of separation of the flows of newly diagnosed TB patients and retreatment TB cases, incl. multidrug-resistant TB.
About the Authors
S. A. Sterlikov
ФГБУ «Центральный НИИ организации и информатизации здравоохранения» Минздрава России
Russian Federation
Russian Federation
L. I. Rusakova
ФГБНУ «Центральный НИИ туберкулеза»
Russian Federation
Russian Federation
E. M. Belilovsky
ГБУЗ «Московский городской научно-практический центр борьбы с туберкулезом Департамента здравоохранения города Москвы»
Russian Federation
Russian Federation
S. B. Ponomarev
ФКУ «НИИ Федеральной службы исполнения наказаний России», Ижевский филиал, Республика Удмуртия, г. Ижевск.
Russian Federation
Russian Federation
References
1. Васильева И.А., Белиловский Е.М., Борисов С.Е., Стерликов С.А. Туберкулез с множественной лекарственной устойчивостью в странах мира и в Российской Федерации // Туберкулез и болезни легких: Избранное 2009–2017. – С. 36-48.
2. О введении в действие учетной и отчетной документации мониторинга туберкулеза: приказ Минздрава России от 13.02.2004 г. № 50. – Тверь: Триада, 2004. – 48 с.
3. Отраслевые и экономические показатели противотуберкулезной работы в 2015–2016 гг. Статистические материалы. – М.: РИО ЦНИИОИЗ, 2017. – 54 с.
4. Dheda K., Gumbo T., Maartens G. et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drugresistant, and incurable tuberculosis // Lancet Resp. Med. – Vol. 5. – N. 4. – С. 291-360.
5. Global Tuberculosis Report 2012. WHO/HTM/TB/2012.6. – Geneva: WHO, 2013. – 282 с. [Электронный ресурс] URL: http://www.who.int/tb/publications/global_report/gtbr12_main.pdf. (Дата обращения 12.12.2017 г.).
6. Global Tuberculosis Report 2013. WHO/HTM/TB/2013.13. – Geneva: WHO, 2013. – 289 с. [Электронный ресурс] URL: http://apps.who.int/iris/handle/10665/91355. (Дата обращения 12.12.2017 г.).
7. Global Tuberculosis Report 2014. WHO/HTM/TB/2014.08. – Geneva: WHO, 2014. – 171 с. [Электронный ресурс] URL: http://apps.who.int/medicinedocs/documents/s21634en/s21634en.pdf. (Дата обращения 12.12.2017 г.).
8. Global Tuberculosis Report 2015. – Geneva: WHO, 2015. – 192 с. [Электронный ресурс] URL: (Дата обращения 12.12.2017 г.).
9. Global Tuberculosis Report 2016. WHO/HTM/TB/2016.13. – Geneva: WHO, 2016. – 201 с. [Электронный ресурс] URL: http://apps.who.int/medicinedocs/documents/s23098en/s23098en.pdf. (Дата обращения 12.12.2017 г.).
10. Global Tuberculosis Report 2017. WHO/HTM/TB/2017.23. – Geneva: WHO, 2017. – 249 с. [Электронный ресурс] URL: http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf (Дата обращения 12.12.2017 г.).
Review
For citations:
Sterlikov S.A., Rusakova L.I., Belilovsky E.M., Ponomarev S.B. Frequency estimation OF tuberculosis with extensively drug resistance in patients of diff erent registration groups. Tuberculosis and socially significant diseases. 2018;(1):6-11. (In Russ.)
Views:
35
Email this article 